Status:
WITHDRAWN
Oral Thiamine for the Treatment of Painful Diabetic Peripheral Neuropathy
Lead Sponsor:
Loma Linda University
Conditions:
Peripheral Neuropathy
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will examine the effect of oral thiamine (Vitamin B1) supplementation on pain in patients with diabetic peripheral neuropathy.
Detailed Description
It is estimated that more then 5 million people in the United States suffer from Diabetes Mellitus, and of these up to 80% suffer from painful diabetic peripheral neuropathy. Multiple medications have...
Eligibility Criteria
Inclusion
- Diagnosis of Diabetes Mellitus Painful diabetic neuropathy for \> six months with a score of \>40mm on a visual pain analog scale Age \>18 years Hemoglobin A1c obtained within the last 3 months. Willingness and ability to comply with the study requirements and give informed consent.
Exclusion
- Known history of alcohol abuse, recreational drug abuse, thyroid dysfunction, syphilis, multiple myeloma, known nutrient deficiency, history of gastric bypass surgery or HIV. Hgb A1c\>11
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00279266
Start Date
January 1 2006
End Date
June 1 2006
Last Update
May 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Department of Neurology
Loma Linda, California, United States, 92354